The 52-Week-High List: 28 Mid Cap Names On Wednesday
A fresh list of market leaders shows different paths to new highs, from steady gains to explosive monthly runs.
As of Wednesday, August 5, 28 Mid Cap stocks are trading at their 52-week highs. The largest is Revolution Medicines (RVMD), with a market value of about $39.1 billion. But the list reveals very different kinds of strength, from steady climbers to names with sharp recent gains.
The central question is whether the underlying business performance supports the new price. The full list of names follows.
The 10 Largest, By Market Cap
The table below shows the 10 largest of the 28 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| RVMD | $39.1 Bil | 2.0% | 9.1% | 3.6% | 430.7% |
| EXPE | $38.9 Bil | 2.4% | 5.1% | 18.4% | 74.2% |
| RJF | $35.4 Bil | 1.1% | 3.7% | 7.7% | 9.9% |
| ATI | $28.0 Bil | 2.5% | 15.3% | 11.9% | 171.2% |
| SN | $25.7 Bil | 8.3% | 14.4% | 20.7% | 56.6% |
| ARXS | $24.1 Bil | 2.7% | 40.3% | 40.3% | n/a |
| PKG | $22.7 Bil | 0.2% | 2.6% | 10.2% | 35.9% |
| IFF | $22.5 Bil | 8.9% | 10.6% | 7.6% | 28.6% |
| RS | $21.7 Bil | 1.5% | 4.3% | 11.0% | 50.3% |
| MGA | $20.0 Bil | 2.5% | 3.8% | 11.6% | 79.7% |
Which new highs are backed by business growth?
Consider Expedia (EXPE), which has gained 18.4% over the last month, far outpacing the S&P 500’s +3.0% return. That run is accompanied by real business expansion: its revenue grew 10.0% over the last twelve months, with an operating margin of 16.1%. The stock trades at 26.2 times trailing earnings.
Contrast that with ATI (ATI), also at a high. It trades at a much steeper 65.9 times trailing earnings, while its revenue grew just 2.9% over the same period.
Is a 52-week high a signal to buy?
A list of stocks at their strongest price of the last year is a useful screen for strength. Strong stocks often continue to perform well. But a high is a price, not a verdict. It marks a moment where the market is most optimistic.
The disciplined move is to treat the list as a starting point for research, asking if the business fundamentals truly earn the new valuation.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks, which is the momentum that tends to have staying power.
New Highs Fade. Discipline Compounds
Some of the names on this list will keep setting highs for years, and some are at the top of their run right now. Sorting one from the other, name by name, every day, is the work most investors never keep up with.
That sorting is what the Trefis High Quality (HQ) Portfolio does systematically: about 30 quality businesses screened for the fundamentals that sustain a run, held with rules instead of excitement. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Use the high list for ideas; use the portfolio for the compounding.